Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice

Cancer Research

Volumn 70, Issue 15, 2010, Pages 6238-6246

  Okazaki, Fumiyasu ^a   Matsunaga, Naoya ^a   Okazaki, Hiroyuki ^a   Utoguchi, Naoki ^b   Suzuki, Ryo ^b   Maruyama, Kazuo ^b   Koyanagi, Satoru ^a   Ohdo, Shigehiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; CRYPTOCHROME; MESSENGER RNA; OXALIPLATIN; SMALL INTERFERING RNA; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CIRCADIAN RHYTHM; COLON CANCER; CONJUGATION; CONTROLLED STUDY; ENZYME ANALYSIS; GENE DEC; GENE EXPRESSION; GENE PERIOD; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANIMALS; CIRCADIAN RHYTHM; COLONIC NEOPLASMS; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; ORGANOPLATINUM COMPOUNDS; PLATINUM; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; TRANSFERRIN;

EID: 77955361748     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0184     Document Type: Article

References (26)

1. Stephan FK, Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A 1972;69:1583-6.
2. Alvarez JD, Sehgal A. Circadian rhythms: finer clock control. Nature 2002;419:798-9. (Pubitemid 35238554)
3. Gekakis N, Staknis D, Nguyen HB, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998;280:1564-9.
4. Kume K, Zylka MJ, Sriram S, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999;98:193-205.
5. Preitner N, Damiola F, Lopez-Molina L, et al. The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002;110:251-60. (Pubitemid 34876552)
6. Sato TK, Yamada RG, Ukai H, et al. Feedback repression is required for mammalian circadian clock function. Nat Genet 2006;38:312-9. (Pubitemid 43315753)
7. Koyanagi S, Kuramoto Y, Nakagawa H, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 2003;63:7277-83. (Pubitemid 37413468)
8. Daniels TR, Delgado T, Helguera G, Penichet ML. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol 2006;121:159-76. (Pubitemid 44572972)
9. Sorokin LM, Morgan EH, Yeoh GC. Transformation-induced changes in transferrin and iron metabolism in myogenic cells. Cancer Res 1989;49:1941-7.
10. Niitsu Y, Kohgo Y, Nishisato T, et al. Transferrin receptors in human cancerous tissues. Tohoku J Exp Med 1987;153:239-43. (Pubitemid 18037720)
11. Calzolari A, Oliviero I, Deaglio S, et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol Dis 2007;39:82-91. (Pubitemid 46754920)
12. Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, Koeffler HP. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. Blood 2001;98:2714-9.
13. Röhrs S, Kutzner N, Vlad A, Grunwald T, Ziegler S, Müller O. Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, TfRc, Plf1 and Ramp3. Cell Biol Int 2009;33:501-8.
14. Papahadjopoulos D, Allen TM, Gabizon A, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 1991;88:11460-4.
15. Ishida O, Maruyama K, Tanahashi H, et al. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm Res 2001;18:1042-8. (Pubitemid 32799953)
16. Suzuki R, Takizawa T, Kuwata Y, et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm 2008;346:143-50.
17. Ohdo S, Koyanagi S, Suyama H, Higuchi S, Aramaki H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat Med 2001;3:356-60. (Pubitemid 32224353)
18. Holloway K, Sade H, Romero IA, Male D. Action of transcription factors in the control of transferrin receptor expression in human brain endothelium. J Mol Biol 2007;365:1271-84.
19. O'Donnell KA, Yu D, Zeller KI, et al. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol. Cell Biol 2006;26:2373-86.
20. Oishi K, Miyazaki K, Kadota K, et al. Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J Biol Chem 2003;278:41519-27.
21. Takiguchi T, Tomita M, Matsunaga N, Nakagawa H, Koyanagi S, Ohdo S. Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells. Pharmacogenet Genomics 2007;17:1047-56. (Pubitemid 351339489)
22. Wittekindt NE, Hörtnagel K, Geltinger C, Polack A. Activation of c-myc promoter P1 by immunoglobulin ê gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs êB, E box 1 and E box 2, and of the 3′ enhancer motif PU. Nucleic Acids Res 2000;28:800-8.
23. Reymann S, Borlak J. Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network. BMC Syst Biol 2008;2:46.
24. Weaver ReppertSM. Coordination of circadian timing in mammals. Nature 2002;418:935-41.
25. Muñoz E, Brewer M, Baler R. Modulation of BMAL/CLOCK/E-Box complex activity by a CT-rich cis-acting element. Mol Cell Endocrinol 2006;252:74-81. (Pubitemid 43914083)
26. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.